...
首页> 外文期刊>British journal of ophthalmology >Korean patients taking α1-adrenergic receptor antagonists show lower incidence of intraoperative floppy iris syndrome than western patients.
【24h】

Korean patients taking α1-adrenergic receptor antagonists show lower incidence of intraoperative floppy iris syndrome than western patients.

机译:韩国患者服用α1-肾上腺素能受体拮抗剂的患者术中软性虹膜综合征的发生率比西方患者低。

获取原文
获取原文并翻译 | 示例

摘要

IFIS occurred only in six eyes of four patients on systemic α1-ARA medications (0.8%). Pupil diameter in the α1-ARA medication group and the control group was not significantly different. The difference in mean DMR thickness in patients taking an α1-ARA and in the control group was also not statistically significant (p=0.641). However, within the α1-ARA population, the DMR thickness of IFIS cases was significantly lower than that of non-IFIS cases (p=0.013) CONCLUSIONS: The overall incidence of IFIS was far lower in Korean patients than that reported for western patients. IFIS patients taking α1-ARAs showed significantly greater iris DMR thinning than non-IFIS patients taking α1-ARAs. Our findings indicate that the interaction between α1-ARAs and melanin, which results in iris DMR atrophy and IFIS, is less strong in Korean patients (with dark irises) than western patients.
机译:IFIS仅在全身性α1-ARA药物治疗的四名患者的六只眼中发生(0.8%)。 α1-ARA药物组的瞳孔直径与对照组无显着差异。服用α1-ARA的患者与对照组的平均DMR厚度差异也无统计学意义(p = 0.641)。但是,在α1-ARA人群中,IFIS病例的DMR厚度显着低于非IFIS病例(p = 0.013)。结论:韩国患者IFIS的总发生率远低于西方患者。服用α1-ARAs的IFIS患者的虹膜DMR变薄明显大于服用α1-ARAs的非IFIS患者。我们的发现表明,韩国患者(深色虹膜)的α1-ARAs与黑色素之间的相互作用弱于虹膜DMR萎缩和IFIS,而西方患者则较弱。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号